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Pathogens require protein-folding enzymes to produce functional virulence
determinants. These foldases include the Dsb family of proteins, which catalyze
oxidative folding in bacteria. Bacterial disulfide catalytic processes have been
well characterized in Escherichia coli K-12 and these mechanisms have been
extrapolated to other organisms. However, recent research indicates that the
K-12 complement of Dsb proteins is not common to all bacteria. Importantly,
many pathogenic bacteria have an extended arsenal of Dsb catalysts that is
linked to their virulence. To help to elucidate the process of oxidative folding in
pathogens containing a wide repertoire of Dsb proteins, Salmonella enterica
serovar Typhimurium has been focused on. This Gram-negative bacterium
contains three DsbA proteins: SeDsbA, SeDsbL and SeSrgA. Here, the
expression, purification, crystallization and preliminary diffraction analysis of
these three proteins are reported. SeDsbA, SeDsbL and SeSrgA crystals
diffracted to resolution limits of 1.55, 1.57 and 2.6 A˚ and belonged to space
groups P21, P21212 and C2, respectively.
1. Introduction
Organisms have evolved complex machineries to support disulfide
catalysis in proteins, a process called oxidative protein folding. The
disulfide-bond (Dsb) proteins catalyze the formation of disulfide
bonds during protein folding in bacteria (Kadokura et al., 2003; Masip
et al., 2004). Escherichia coli K-12 contains two pathways to regulate
the oxidative-folding process: in the oxidative pathway DsbA and
DsbB (Bardwell et al., 1991, 1993; Akiyama et al., 1992) introduce
disulfide bonds into target proteins and in the isomerase pathway
DsbC, DsbG and DsbD (Rietsch et al., 1996) catalyze the reshuffling
of incorrect disulfide bonds.
The Dsb systems described for E. coli K-12 are not completely
conserved in bacteria (Dutton et al., 2008; Heras et al., 2009); many
Gram-negative pathogens encode an extended arsenal of Dsb
proteins which may assist in the production of virulence factors
(Heras et al., 2009; Sinha et al., 2004). For example, Neisseria
meningitidis, the causative agent of meningitis and meningococcal
septicaemia, encodes three different DsbA-like proteins: NmDsbA1
and NmDsbA2 are lipoproteins anchored to the inner membrane,
while NmDsbA3 is a soluble periplasmic protein (Sinha et al., 2004;
Tinsley et al., 2004). Two of these proteins, NmDsbA1 and NmDsbA3,
have been structurally characterized and the disulfide-oxidation
mechanism in this pathogen has been investigated (Vivian et al., 2008,
2009; Lafaye et al., 2009). Multiple Dsb proteins are also found in
uropathogenic E. coli (UPEC), which contains a DsbL/DsbI pair in
addition to the oxidase and isomerase pathways found in the proto-
typic K-12 (Grimshaw et al., 2008; Totsika et al., 2009).
The mechanisms for disulfide catalysis in Gram-negative pathogens
with an extended collection of Dsb proteins mostly remain unchar-
acterized. To further investigate oxidative-folding processes in these
organisms we have focused on Salmonella enterica serovar Typhi-
murium, which encodes the standard DsbA–DsbB and DsbC–DsbD
systems as well as the DsbL/DsbI redox pair and a virulence plasmid-
encoded DsbA-like protein (termed SeSrgA). The three Salmonella
DsbA paralogues, SeDsbA, SeDsbL and SeSrgA, share low sequence
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identity with each other (between 18 and 34%), which might result in
different redox function and substrate specificities. Here, we report
the crystallization and initial diffraction data for these three DsbA-
like oxidoreductases.
2. Material and methods
2.1. Cloning, expression and protein purification
The coding sequences for SeDsbA (Locus Tag SL3945), SeDsbL
(Locus Tag SL3166) and SeSrgA (Locus Tag SLP1_0094) were
amplified by PCR from S. enterica serovar Typhimurium strain
SL1344 genomic DNA. All three genes were amplified using the
Elongase enzyme mix (Invitrogen, Carlsbad, California, USA) and a
protocol that involved an initial denaturation step (3 min at 368 K)
followed by 35 cycles of 368 K for 30 s, 323 K for 30 s and 341 K for
2 min. The primers for the PCR reactions were designed to amplify
only the mature forms of the proteins (lacking the signal peptide)
containing ligation-independent cloning (LIC) overhangs (Table 1).
The amplified genes were subsequently inserted into a modified
version of pET21a vector, which encodes an N-terminal His6 tag
followed by the tobacco etch virus (TEV) protease cleavage site using
LIC cloning (Donnelly et al., 2006). This construct allows the removal
of the tagged signal upon expression and metal-affinity purification.
Three additional residues are introduced at the N-terminus of the
proteins (i.e. SNA) after TEV cleavage.
For crystallization purposes, all three Salmonella proteins were
expressed in E. coli BL21 (DE3) pLysS cells (Invitrogen, Carlsbad,
California, USA) using autoinduction (Studier, 2005). Briefly, cells
harbouring pET/LIC-SeDsbA, pET/LIC-SeDsbL or pET/LIC-
SeSrgAwere grown with agitation at 200 rev min1 for 24 h at 303 K
in minimal medium (Studier, 2005) supplemented with 100 mg ml1
ampicillin and 34 mg ml1 chloramphenicol.
The cells were then harvested by centrifugation and resuspended
in 25 mM Tris pH 7, 150 mM NaCl, 0.5% Triton X-100, Protease
Inhibitor Cocktail 3 (Astral Scientific Pty Ltd, Caringbah, NSW 2229,
Australia) and DNAse (Sigma–Aldrich, St Louis, Misssouri, USA)
and lysed by sonication (using a Sonifier 250, Branson Ultrasonic
Corporation, Danbury, Connecticut, USA). Cell debris was removed
by centrifugation at 41 400g for 30 min and histidine-tagged proteins
were purified using PrepEase His-tagged protein purification resin
(USB Corporation, Cleveland, Ohio, USA; 2 g per 100 ml of lysate).
The proteins bound to the resin were washed extensively with buffer
A (25 mM Tris–HCl pH 7, 0.5M NaCl, 20 mM imidazole) using
gravity flow and eluted in buffer B (25 mM Tris–HCl pH 7, 150 mM
NaCl, 300 mM imidazole). The purified proteins were then cleaved
using recombinant His-tagged TEV protease purified to homogeneity
(Blommel & Fox, 2007). The protease was added to the Dsb protein
samples (0.2 mg of TEV per 10 mg of protein) and dialyzed for 48 h
at 277 K against buffer C (25 mM HEPES–NaOH pH 7, 150 mM
NaCl). After removing the His-tagged TEV protease from the
dialysed samples by batch treatment with PrepEase Ni2+-affinity
resin, the proteins were further purified by gel-filtration chromato-
graphy (A¨KTA, GE Healthcare, Piscataway, New Jersey, USA) using
a Superdex S-75 (GE Healthcare, Piscataway, New Jersey, USA)
column pre-equilibrated in buffer C. SeDsbA was purified to homo-
geneity (Fig. 1) by ion-exchange chromatography on a Mono Q 5/50
GL (GE Healthcare, Piscataway, New Jersey, USA) using buffer D
consisting of 25 mM HEPES–NaOH pH 7.5, 50 mM NaCl and buffer
E consisting of 25 mM HEPES–NaOH pH 7.5, 500 mM NaCl
(gradient of 0–60% buffer E over 60 min). SeDsbL and SeSrgAwere
further purified by cation-exchange chromatography (Mono S 5/50
GL column, GE Healthcare, Piscataway, New Jersey, USA) using
buffer F consisting of 25 mM HEPES–NaOH pH 6.7, 50 mM NaCl
and buffer G consisting of 25 mM HEPES–NaOH pH 6.7, 500 mM
NaCl (gradient of 0–60% buffer G over 60 min; Fig. 1).
All proteins were oxidized by the addition of 1.7 mM copper(II)-
1,10-phenanthroline (1 h, 277 K) and then equilibrated in buffer F
using a PD-10 column (GE Healthcare, Piscataway, New Jersey,
USA).
SeDsbA, SeDsbL and SeSrgA protein samples were concentrated
to 82, 29 and 20 mg ml1, respectively, in buffer F using Amicon Ultra
centrifugal filter devices (10 kDa cutoff; Millipore, Billerica, Massa-
chusetts, USA). Protein concentration was measured at 280 nm using
a NanoDrop ND-1000 (Thermo Scientific, Wilmington, Delaware,
USA) and the purity was assessed by SDS–PAGE analysis and mass
spectrometry.
2.2. Crystallization
Initial vapour-diffusion crystallization experiments were per-
formed in 96-well hanging-drop plates (96-well tissue-culture plates
sourced from Lomb Scientific Pty Ltd, Taren Point, NSW, Australia)
using ViewDrop II plate seals (TTP LabTech Ltd, Melbourn, UK)
and commercial crystallization screens including PEG/Ion, PEG/Ion
2, Index Screen (Hampton Research, Aliso Viejo, California, USA),
PACT Premier, JCSG-plus (Molecular Dimensions Limited, New-
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Table 1
Primers used for the amplification of SedsbA, SedsbL and SesrgA.
Nucleotides in bold represent the ligation-independent cloning (LIC) overhangs.
Primer (50–30) Protein
TACTTCCAATCCAATGCGGCACAGATCAG Forward SeDsbA
TTATCCACTTCCAATGTTATTTTTTATCAACC Reverse SeDsbA
TACTTCCAATCCAATGCGTTTACCGAGGGCAC Forward SeDsbL
TTATCCACTTCCAATGTTATTTTTTAGTGGCCAGTTC Reverse SeDsbL
TACTTCCAATCCAATGCGCAGGAGTGGGAG Forward SeSrgA
TTATCCACTTCCAATGTCAGTCTGCATCAGGG Reverse SeSrgA
Figure 1
SDS–PAGE analysis of SeDsbA, SeDsbL and SeSrgA. Proteins were analyzed on
NuPAGE Novex 4–12% bis-tris gels run using NuPAGE MES SDS running buffer
(Invitrogen, Carlsbad, California, USA) and stained with Coomassie Blue. Lane 1,
purified SeSrgA; lane 2, purified SeDsbL; lane 3, purified SeDsbA; lane M,
molecular-weight markers (Low Molecular Weight Calibration Kit for Electro-
phoresis, GE Healthcare, Piscataway, New Jersey, USA; labelled in kDa).
market, UK), Precipitant Synergy (Jena Bioscience, Jena, Germany)
and an in-house malonate grid screen pH 5–7 and 0.2–3.4M. The
crystallization plates contained 85 ml of the crystallization solutions
placed using a Biomek 2000 Laboratory Automation workstation
(Beckman Coulter Inc., Brea, California, USA). Crystallization drops
consisting of 100 nl protein solution and 100 nl reservoir solution
solution were prepared using a Mosquito robot (TTP LabTech Ltd,
Melbourn, UK). The plates were incubated at 293 K and monitored
and scored using a Rock Imager and Rock Maker system (Formula-
trix Inc,. Waltham, Massachusetts, USA).
SeDsbA crystals grew in six different conditions consisting of (i)
25%(w/v) polyethylene glycol (PEG) 3350 and 100 mM Tris pH 8.5;
(ii) 20%(w/v) PEG 8000 and 100 mM N-cyclohexyl-2-aminoethane-
sulfonic acid (CHES) pH 9.5; (iii) 20%(w/v) PEG 3350, 100 mM bis-
tris propane pH 7.5, 200 mM sodium formate; (iv) 20%(w/v) PEG
3350, 100 mM bis-tris propane pH 8.5, 200 mM sodium nitrate; (v)
20%(w/v) PEG 3350, 100 mM bis-tris propane pH 8.5, 200 mM
sodium formate and (vi) 20%(w/v) PEG 3350, 100 mM bis-tris
propane pH 8.5, 200 mM sodium acetate. Crystals of SeDsbL were
observed in two conditions: (i) 1.6M trisodium citrate dihydrate pH
6.5 and (ii) 2.9M sodium malonate pH 7.0. SeSrgA crystals grew in
1.1M sodium malonate, 0.5%(w/v) Jeffamine ED-2001, 100 mM
HEPES pH 7. Crystal optimization experiments were carried out at
293 K in 24-well hanging-drop VDXm plates using 18 mm siliconized
cover slips (Hampton Research, Aliso Viejo, California, USA), a
reservoir volume of 500 ml and a drop size of 2 ml. Given the good
quality and size of the SeDsbA crystals obtained in the initial screens,
we only replicated these conditions in the 24-well plates; a total of
about six droplets produced enough crystals for SeDsbA diffraction
experiments which grew overnight in 20%(w/v) PEG 3350, 100 mM
bis-tris propane pH 8.5, 200 mM sodium acetate. SeDsbL crystals
were optimized by setting up a 24-well plate screening different
concentrations of sodium malonate (3.2–2.6M) and pH (pH 6.8–7.4).
Each cover slip held two 2 ml drops with two different ratios of
protein to well solution (1:1 and 1.2:0.8). SeDsbL crystals grew in 2 d
in most conditions. For SeSrgAwe initially set up a grid screen based
on the initial hit, in which the concentrations of sodium malonate and
Jeffamine were varied from 0.9 to 1.4M and from 0.3% to 1%,
respectively. Crystals only appeared in the conditions with the highest
sodium malonate concentration, while changing the Jeffamine con-
centration did not have any noticeable effect. To further optimize
SeSrgA crystals we then set up a 24-well plate in which we modified
the sodium malonate concentration (from 1.25 to 1.5M in increments
of 0.05M) and tested four different pH values (6, 6.25, 6.5 and 7).
Each cover slip contained two drops with two different ratios of
protein to well solution (1:1 and 0.75:1.25). Diffraction-quality crys-
tals of SeSrgA grew within 6–10 d in conditions consisting of 1.25–
1.5M sodium malonate and with pH values between 6 and 6.5.
2.3. X-ray diffraction data measurement
X-ray diffraction data for SeDsbA and SeDsbL crystals were
collected on the high-throughput protein crystallography beamline
(MX1 beamline 3BM1) at the Australian Synchrotron using an
ADSC Quantum 210r CCD detector. Crystals of the two proteins
were cryoprotected by soaking them for 2 min in mother liquor
supplemented with PEG 400 (the reservoir solution was diluted with
PEG 400 to obtain a final PEG concentration of 20%). 360 and 180
images were collected for SeDsbA and SeDsbL, respectively, with an
oscillation angle of 1 per image under cryogenic conditions (100 K)
and an exposure time of 1 s. Diffraction data were indexed, integrated
and scaled using HKL-2000 (Otwinowski & Minor, 1997).
SeSrgA diffraction images were measured in-house using a Rigaku
FR-E copper rotating-anode generator operating at 45 kVand 45 mA
with Osmic Confocal Vari-Max HFoptics at a wavelength of 1.5418 A˚
(Rigaku Americas, The Woodlands, Texas, USA). Reflections were
measured using a Rigaku Saturn 944 CCD area detector (Rigaku
Americas, TheWoodlands, Texas, USA). ACryo Industries CryoCool
LN2 (Cryo Industries, Manchester, New Hampshire, USA) was used
to keep the SeSrgA crystals at 100 K during data collection. Prior to
data collection, SeSrgA crystals were transferred into cryoprotectant
solution consisting of mother liquor supplemented with PEG 400 (as
described for SeDsbA and SeDsbL). For diffraction experiments we
used a crystal-to-detector distance of 70 mm and oscillation images
were collected every 0.5 over a total of 180 with an exposure time of
15 s. Diffraction data were processed using CrystalClear v.1.4 (Rigaku
Americas, The Woodlands, Texas, USA).
3. Results and discussion
Three genes (SedsbA, SedsbL and SesrgA) encoding homologues
of the thiol-disulfide oxidoreductase DsbA in S. enterica serovar
Typhimurium SL1344 were cloned into pET21a-LIC vector and
expressed in BL21 (DE3) pLysS cells. Three consecutive chromato-
graphy steps (affinity, size-exclusion and ion-exchange chromato-
graphy) were used to purify the recombinant SeDsbA, SeDsbL and
SeSrgA proteins to homogeneity for crystallization trials. Crystals of
SeDsbA, SeDsbL and SeSrgA were observed under different crys-
tallization conditions, which yielded well diffracting single crystals
upon optimization. SeDsbA crystals grew using a reservoir solution
consisting of 20%(w/v) PEG 3350, 100 mM bis-tris propane pH 8.5,
200 mM sodium acetate, SeDsbL crystallized in 2.6–3.4M sodium
malonate pH 7.0–7.4 and single crystals of SeSrgA were obtained in
1.45M sodium malonate, 0.5%(w/v) Jeffamine ED-2001, 100 mM
HEPES pH 7 (Fig. 2). SeDsbA, SeDsbL and SeSrgA crystals
diffracted to resolution limits of 1.55, 1.57 and 2.6 A˚ and belonged to
space groups P21, P21212 and C2, respectively. Assuming that the
crystallization communications
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Figure 2
Crystals of (a) SeDsbA, (b) SeDsbL and (c) SeSrgA obtained using the hanging-drop vapour-diffusion method. The crystals reached typical dimensions of 0.16 0.05 0.8,
0.1  0.05  1.3 and 0.1  0.1  0.4 mm, respectively. The scale bars represent 0.1 mm.
crystals contain one molecule per asymmetric unit for SeDsbA and
SeDsbL and five molecules per asymmetric unit for SeSrgA, the
Matthews coefficients (VM) are 2.4, 2.7 and 3.3 A˚
3 Da1, respectively,
and the corresponding solvent contents are 49.2, 53.9 and 62.3%
(Matthews, 1968). Statistics for the diffraction data are provided in
Table 2.
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Table 2
Summary of X-ray data-measurement and processing statistics.
Values in parentheses are for the highest resolution shell.
SeDsbA SeDsbL SeSrgA
Wavelength (A˚) 0.956667 0.956667 1.5418
Temperature (K) 100 100 100
Space group P21 P21212 C2
Unit-cell parameters (A˚, ) a = 37.3, b = 61.7,
c = 42.8,
 =  = 90,
 = 101.3
a = 85.6, b = 46.6,
c = 60.2,
 =  =  = 90
a = 186.3, b = 80.3,
c = 105.5,
 =  = 90,
 = 124.3
Anticipated solvent content
(%)
49.2 53.9 62.3
Resolution range 50.0–1.55
(1.58–1.55)
50.0–1.57
(1.60–1.57)
36.4–2.6
(2.7–2.6)
No. of observations 192033 246716 134920
No. of unique reflections 26275 (1039) 34491 (1693) 37521 (3734)
Redundancy 7.3 (6.6) 7.2 (7.0) 3.6 (3.4)
Completeness (%) 94.2 (75.7) 99.9 (100) 99.8 (99.4)
Rmerge† 0.082 (0.217) 0.066 (0.459) 0.12 (0.425)
I/(I) 19.5 (8.5) 29.6 (4.1) 6.1 (2.0)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the measured
intensity of each individual reflection and hI(hkl)i is the mean value of the intensity.
